Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.625 USD | +3.35% | +22.46% | -3.22% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.22% | 3.72M | |
+3.95% | 111B | |
+11.45% | 105B | |
-12.55% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.67% | 16.96B | |
+3.11% | 13.7B | |
+37.02% | 12.45B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Transcript : Cyclacel Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 11, 2022